RayzeBio Common Stock Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and RayzeBio, Common are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days RayzeBio Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, RayzeBio, Common is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 215.9 M | |
| Free Cash Flow | -90.7 M |
RayzeBio, |
RayzeBio, Common Relative Risk vs. Return Landscape
If you would invest (100.00) in RayzeBio Common Stock on November 17, 2025 and sell it today you would earn a total of 100.00 from holding RayzeBio Common Stock or generate -100.0% return on investment over 90 days. RayzeBio Common Stock is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than RayzeBio,, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
RayzeBio, Common Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RayzeBio, Common for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RayzeBio Common Stock can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RayzeBio, Common is not yet fully synchronised with the market data | |
| RayzeBio, Common has some characteristics of a very speculative penny stock | |
| RayzeBio, Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (63.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RayzeBio, Common generates negative cash flow from operations | |
| Over 90.0% of the company shares are owned by institutional investors |
RayzeBio, Common Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of RayzeBio, Stock often depends not only on the future outlook of the current and potential RayzeBio, Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RayzeBio, Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.2 M | |
| Cash And Short Term Investments | 296.2 M |
RayzeBio, Common Fundamentals Growth
RayzeBio, Stock prices reflect investors' perceptions of the future prospects and financial health of RayzeBio, Common, and RayzeBio, Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RayzeBio, Stock performance.
| Current Valuation | 3.19 B | |||
| Shares Outstanding | 60.02 M | |||
| Price To Book | 6.46 X | |||
| EBITDA | (73.86 M) | |||
| Total Debt | 10.57 M | |||
| Book Value Per Share | 9.62 X | |||
| Cash Flow From Operations | (56.05 M) | |||
| Earnings Per Share | (1.08) X | |||
| Total Asset | 324.78 M | |||
| Retained Earnings | (130.12 M) | |||
Things to note about RayzeBio Common Stock performance evaluation
Checking the ongoing alerts about RayzeBio, Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RayzeBio Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RayzeBio, Common is not yet fully synchronised with the market data | |
| RayzeBio, Common has some characteristics of a very speculative penny stock | |
| RayzeBio, Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (63.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RayzeBio, Common generates negative cash flow from operations | |
| Over 90.0% of the company shares are owned by institutional investors |
- Analyzing RayzeBio, Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RayzeBio, Common's stock is overvalued or undervalued compared to its peers.
- Examining RayzeBio, Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RayzeBio, Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RayzeBio, Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RayzeBio, Common's stock. These opinions can provide insight into RayzeBio, Common's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in RayzeBio, Stock
If you are still planning to invest in RayzeBio Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RayzeBio, Common's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |